Search

everythinglearnresearchcommunity

for

Search:↓

Androgens significantly affect female hair loss, and hormonal treatments may help.

Use "female pattern hair loss" term, finasteride may help, more research needed.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Camouflaging agents like hair fibers and wigs significantly improve appearance and self-esteem for most hair loss patients.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Liposomes improve finasteride delivery for hair loss treatment, making it a promising option for topical use.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Finasteride improves hidradenitis suppurativa but not for child-bearing women.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Oral isotretinoin effectively treats yellow facial papules in frontal fibrosing alopecia patients.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

Women with hyperandrogenic amenorrhea have similar bone density to healthy women but lower than androgenized women without amenorrhea, and high DHEAS levels might affect bone density.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

PCOS is a common hormonal disorder in women, treated with lifestyle changes, medication, and patient education.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

This text talks about how to treat hair loss in women. It suggests different options and stresses the importance of support.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Using 3% topical minoxidil can help women with hair loss, but more research is needed.

Using a teletriage system greatly increased access to skin care for uninsured Latino immigrants at a clinic.

Androgens affect many aspects of female health, and more research is needed to understand their roles and treatment potential.